{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:12:23Z","timestamp":1759047143865,"version":"3.41.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Extranodal NK\/T-cell lymphoma, nasal type (ENKTCL-NT), is an aggressive malignancy primarily affecting the sinonasal region, with a strong association with Epstein-Barr virus (EBV) infection. The disease is significantly more prevalent in Asian and Latin American populations. Diagnosis is particularly challenging in nonendemic regions. We present the case of a 78-year-old male with a one-year history of nasal lesions, later diagnosed with ENKTCL-NT. The patient was treated with curative-intent radiotherapy, achieving a complete clinical response. Radiation therapy, particularly utilizing advanced techniques such as Volumetric Modulated Arc Therapy (VMAT), resulted in favorable outcomes with minimal toxicity. This case emphasizes the importance of early diagnosis, accurate staging, and personalized radiotherapy in the management of ENKTCL-NT. Ongoing research into the molecular pathogenesis, treatment strategies, and prognostic factors is crucial for improving outcomes, particularly in advanced-stage disease.<\/jats:p>","DOI":"10.1007\/s00277-025-06260-x","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:36:39Z","timestamp":1743827799000},"page":"3001-3006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiotherapy alone with curative intent in a case of limited-stage extranodal NK\/T-cell lymphoma nasal type: a case report and review of the literature"],"prefix":"10.1007","volume":"104","author":[{"given":"Biancamaria","family":"Mandelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Caivano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Cenfra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Mecarocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maristella","family":"Marrocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fanciullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Mazzarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Lorenzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Pacitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Pulsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"6260_CR1","doi-asserted-by":"publisher","first-page":"103237","DOI":"10.1016\/j.critrevonc.2021.103237","volume":"159","author":"C S\u00e1nchez-Romero","year":"2021","unstructured":"S\u00e1nchez-Romero C, Bologna-Molina R, De Almeida et al (2021) Extranodal NK\/T cell lymphoma, nasal type: an updated overview. Crit Rev Oncol Hematol 159:103237. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103237","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"6260_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/0973-029x.80016","volume":"15","author":"R Metgud","year":"2011","unstructured":"Metgud R, Doshi J, Gaurkhede S et al (2011) Extranodal NK\/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): a review about the terminology. J Oral Maxillofac Pathol 15(1):96\u2013100. https:\/\/doi.org\/10.4103\/0973-029x.80016","journal-title":"J Oral Maxillofac Pathol"},{"key":"6260_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijrobp.2016.09.013","volume":"97","author":"RY Wu","year":"2017","unstructured":"Wu RY, Liu K, Wang WH et al (2017) Patterns of primary tumor invasion and regional lymph node spread based on MRI in early-stage nasal NK\/T-cell lymphoma: implications for clinical target volume definition and prognostic significance. Int J Radiat Oncol Biol Phys 97:50\u201359. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.09.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6260_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","volume":"128","author":"M Lambrecht","year":"2018","unstructured":"Lambrecht M, Eekers DBP, Alapetite C et al (2018) Radiation dose constraints for organs at risk in neuro-oncology; the European particle Therapy Network consensus. Radiother Oncol 128:26\u201336. https:\/\/doi.org\/10.1016\/j.radonc.2018.05.001","journal-title":"Radiother Oncol"},{"issue":"5","key":"6260_CR5","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.ijrobp.2010.10.040","volume":"82","author":"Y Li","year":"2011","unstructured":"Li Y, Wang H, Jin J, Wang W et al (2011) Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK\/T-Cell lymphoma. Int J Radiation Oncology*Biology*Physics 82(5):1809\u20131815. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.10.040","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"9","key":"6260_CR6","doi-asserted-by":"publisher","first-page":"e106577","DOI":"10.1371\/journal.pone.0106577","volume":"9","author":"T Deng","year":"2014","unstructured":"Deng T, Zhang C, Zhang X et al (2014) Treatment Outcome of Radiotherapy Alone versus Radiochemotherapy in IE\/IIE Extranodal nasal-type natural Killer\/T cell lymphoma: a Meta-analysis. PLoS ONE 9(9):e106577. https:\/\/doi.org\/10.1371\/journal.pone.0106577","journal-title":"PLoS ONE"},{"key":"6260_CR7","doi-asserted-by":"publisher","unstructured":"Qi S, Li Y, Specht L, Dose Guidelines from the International Lymphoma Radiation Oncology Group (2021) Modern Radiation Therapy for Extranodal Nasal-Type NK\/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and. Int J Radiat Oncol Biol Phys. 15;110(4):1064\u20131081. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.02.011","DOI":"10.1016\/j.ijrobp.2021.02.011"},{"key":"6260_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","volume":"24","author":"YX Li","year":"2006","unstructured":"Li YX, Yao B, Jin J et al (2006) Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma. J Clin Oncol 24:181\u2013189. https:\/\/doi.org\/10.1200\/JCO.2005.03.2573","journal-title":"J Clin Oncol"},{"key":"6260_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamaoncol.2016.5094","volume":"3","author":"Y Yang","year":"2017","unstructured":"Yang Y, Cao JZ, Lan SM et al (2017) Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type natural killer\/T-cell lymphoma. JAMA Oncol 3:83\u201391. https:\/\/doi.org\/10.1001\/jamaoncol.2016.5094","journal-title":"JAMA Oncol"},{"key":"6260_CR10","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1002\/cncr.30697","volume":"123","author":"JA Vargo","year":"2017","unstructured":"Vargo JA, Patel A, Glaser SM et al (2017) The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States. Cancer 123:3176\u20133185. https:\/\/doi.org\/10.1002\/cncr.30697","journal-title":"Cancer"},{"issue":"1","key":"6260_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2018.04.026","volume":"129","author":"XW Deng","year":"2018","unstructured":"Deng XW, Wu JX, Wu T et al (2018) Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK\/T-cell lymphoma: a multicenter study from the China Lymphoma Collaborative Group (CLCG). Radiother Oncol 129(1):3\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2018.04.026","journal-title":"Radiother Oncol"},{"issue":"6","key":"6260_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/10245332.2016.1264163","volume":"22","author":"W Wei","year":"2017","unstructured":"Wei W, Wu P, Li L, Zhang ZH (2017) Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer\/T-cell lymphoma. Hematology 22(6):320\u2013329. https:\/\/doi.org\/10.1080\/10245332.2016.1264163","journal-title":"Hematology"},{"key":"6260_CR13","doi-asserted-by":"publisher","first-page":"60504","DOI":"10.18632\/oncotarget.16138","volume":"8","author":"YY Li","year":"2017","unstructured":"Li YY, Lin HQ, Zhang LL et al (2017) Intensity-modulated radiotherapy has superior outcomes to three-dimensional conformal radiotherapy in patients with stage IE-IIE extranodal nasal-type natural killer\/T-cell lymphoma. Oncotarget 8:60504\u201360513. https:\/\/doi.org\/10.18632\/oncotarget.16138","journal-title":"Oncotarget"},{"issue":"18","key":"6260_CR14","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1182\/bloodadvances.2018021311","volume":"2","author":"T Wu","year":"2018","unstructured":"Wu T, Yang Y, Zhu SY et al (2018) Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group. Blood Adv 2(18):2369\u20132377. https:\/\/doi.org\/10.1182\/bloodadvances.2018021311","journal-title":"Blood Adv"},{"key":"6260_CR15","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","volume":"132","author":"BS Dabaja","year":"2018","unstructured":"Dabaja BS, Hoppe BS, Plastaras JP et al (2018) Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood 132:1635\u20131646. https:\/\/doi.org\/10.1182\/blood-2018-03-837633","journal-title":"Blood"},{"key":"6260_CR16","doi-asserted-by":"publisher","unstructured":"De Oliveira Costa R, Pereira J, De P\u00e1dua Covas Lage LA et al (2023) Extranodal NK-\/T-cell lymphoma, nasal type: what advances have been made in the last decade? Front Oncol 13. https:\/\/doi.org\/10.3389\/fonc.2023.1175545","DOI":"10.3389\/fonc.2023.1175545"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06260-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06260-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06260-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T06:37:47Z","timestamp":1749105467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06260-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6260"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06260-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical considerations for this case report have been rigorously followed, ensuring patient confidentiality and obtaining informed consent in accordance with institutional guidelines, ethical standards for medical research publication, and the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"In accordance with the journal\u2019s policies, the authors consent to the publication of this manuscript and confirm that all necessary permissions for third-party materials have been obtained. Additionally, since the manuscript includes details, images, or videos of an individual, explicit consent for publication has been obtained from the individual involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}